mFOLFIRINOX Plus Anlotinib and Sintilimab for Advanced Pancreatic Cancer

Clinical trial NCT06761027 · RECRUITING

Trial details

NCT number: NCT06761027
Sponsor: Fujian Provincial Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2024-12-23
Primary completion: 2027-03-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.